Atrial Fibrillation Clinical Trial
Official title:
Polish Atrial Fibrillation (POL-AF) Registry
Evaluation of clinical characteristics and pharmacotherapy of hospitalized Polish patients with atrial fibrillation (AF).
Atrial fibrillation (AF) is a common arrhythmia associated with increased cardiovascular
mortality. An important element of management of patients with AF is anticoagulation to
prevent thromboembolic events. Non-vitamin K oral anticoagulants (NOACs) and vitamin K
antagonists (VKAs) are two main drugs groups used in thromboembolic events prevention.
Primary objective of the study is to assess the frequency of VKAs vs NOACs prescription in AF
patients treatment of with OACs.
Secondary objective of the study are as follows: assessment of the frequency of
appropriate/inappropriate OACs prescription in AF patients and assesment of the number of
patients with AF treated with apixaban, dabigatran and rivaroxaban with high thromboembolism
risk according to CHA2DS2-VASc score.
The POL-AF Registry is a multicenter prospective analysis of hospital records of patients
with AF managed in ten cardiology centers.
Collected data will include demographics, type of AF (valvular and non-valvular, as well as
paroxysmal, persistent and permanent), medical history, laboratory tests, echocardiographic
parameters and concomitant medications.
Each patient will be evaluated regarding to common scales assessing risk of thromboembolic
(CHA2DS2-VASc) and bleeding (HAS-BLED, modifiable and non-modifiable risk factors for
bleeding in anticoagulated patients basing on the current guidelines for AF treatment)
events.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05654272 -
Development of CIRC Technologies
|
||
Completed |
NCT04571385 -
A Study Evaluating the Efficacy and Safety of AP30663 for Cardioversion in Participants With Atrial Fibrillation (AF)
|
Phase 2 | |
Terminated |
NCT04115735 -
His Bundle Recording From Subclavian Vein
|
||
Completed |
NCT05366803 -
Women's Health Initiative Silent Atrial Fibrillation Recording Study
|
N/A | |
Completed |
NCT02864758 -
Benefit-Risk Of Arterial THrombotic prEvention With Rivaroxaban for Atrial Fibrillation in France
|
||
Recruiting |
NCT05442203 -
Electrocardiogram-based Artificial Intelligence-assisted Detection of Heart Disease
|
N/A | |
Completed |
NCT05599308 -
Evaluation of Blood Pressure Monitor With AFib Screening Feature
|
N/A | |
Completed |
NCT03790917 -
Assessment of Adherence to New Oral anTicoagulants in Atrial Fibrillation patiEnts Within the Outpatient registrY
|
||
Enrolling by invitation |
NCT05890274 -
Atrial Fibrillation (AF) and Electrocardiogram (EKG) Interpretation Project ECHO
|
N/A | |
Recruiting |
NCT05266144 -
Atrial Fibrillation Patients Treated With Catheter Ablation
|
||
Recruiting |
NCT05316870 -
Construction and Effect Evaluation of Anticoagulation Management Model in Atrial Fibrillation
|
N/A | |
Not yet recruiting |
NCT06023784 -
The Impact of LBBAP vs RVP on the Incidence of New-onset Atrial Fibrillation in Patients With Atrioventricular Block
|
N/A | |
Recruiting |
NCT05572814 -
Transform: Teaching, Technology, and Teams
|
N/A | |
Recruiting |
NCT04092985 -
Smart Watch iECG for the Detection of Cardiac Arrhythmias
|
||
Completed |
NCT04087122 -
Evaluate the Efficiency Impact of Conducting Active Temperature Management During Cardiac Cryoablation Procedures
|
N/A | |
Completed |
NCT06283654 -
Relieving the Emergency Department by Using a 1-lead ECG Device for Atrial Fibrillation Patients After Pulmonary Vein Isolation
|
||
Recruiting |
NCT05416086 -
iCLAS™ Cryoablation System Post-Market Clinical Follow-up (PMCF) Study
|
N/A | |
Completed |
NCT05067114 -
Solutions for Atrial Fibrillation Edvocacy (SAFE)
|
||
Completed |
NCT04546763 -
Study Watch AF Detection At Home
|
||
Completed |
NCT03761394 -
Pulsewatch: Smartwatch Monitoring for Atrial Fibrillation After Stroke
|
N/A |